Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 1CNS 1

Conditions

Neuroma, Acoustic 1Neurofibromatosis 2 1Multiple Myeloma 1

Interventions

Cisplatin 516Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 341Paclitaxel 336Oxaliplatin 335Gemcitabine 323Docetaxel 316Fluorouracil 289Drug Therapy 276apatinib 247Bevacizumab 247camrelizumab 219Etoposide 201Irinotecan 181Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145Blood Specimen Collection 140anlotinib 139Pemetrexed 138Cytarabine 138toripalimab 134Surgical Procedures, Operative 131Radiosurgery 130S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × 89Zr-bevacizumab × Clear all
NCT05685836 2024-03-20

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Leiden University Medical Center

Unknown
15 enrolled
CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01859234 2013-05-21

89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma

University Medical Center Groningen

Phase NA Unknown
20 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡